Act Two Investors »

Eli Lilly & Co. shares owned by Act Two Investors

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Act Two Investors from 13F filings

Historical chart of Act Two Investors investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Act Two Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Act Two Investors

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.1M 8.4k 1074.68
2025-09-30 $6.4M 8.4k 763.00

More positions owned by Act Two Investors

Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Iqvia Holdings (IQV)
Visa Com Cl A (V)
Astrazeneca Sponsored Adr
Metropcs Communications (TMUS)
Eversource Energy (ES)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Walt Disney Company (DIS)
Adobe Systems Incorporated (ADBE)
Canadian Natl Ry (CNI)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Act Two Investors

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Wellington Management Company
State Farm Mutual Automobile Insurance Company
Norges Bank Investment Management
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
PRIMECAP Management Company

View all funds holding Eli Lilly & Co.